# Study of Novel Treatment Combination Therapies in Participants With Head and Neck Squamous Cell Carcinoma Regardless of PD-L1 Expression Status; Substudy-01

> clinical trial · VERIFIED · 2026-09-03

Status: ACTIVE_NOT_RECRUITING · Sponsor: Gilead Sciences · Condition: Head and Neck Squamous Cell Carcinoma

- Company: Gilead Sciences
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06727565

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.